
Nanobiotix S.A. NBTX
€ 24.43
-2.83%
Land |
|
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
47.8 B |
Marktkapitalisierung |
$ 1.28 T |
EBITDA (LTM) |
$ -10.8 M |
P/E (LTM) |
-64.7 |
P/S (LTM) |
47463.103533 |
EPS (LTM) |
-0.5 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Daré Bioscience
DARE
|
$ 0.45 | 4.92 % | $ 5.03 M | Nasdaq Capital Market | ||
|
Fate Therapeutics
FATE
|
$ 1.05 | 2.94 % | $ 125 M | Nasdaq Global Market,SPB | ||
|
Greenwich LifeSciences
GLSI
|
$ 20.57 | 10.01 % | $ 278 M | Nasdaq Capital Market | ||
|
Halozyme Therapeutics
HALO
|
$ 95.8 | -0.18 % | $ 11.5 B | Nasdaq Global Select Market,SPB | ||
|
Hutchison China MediTech Limited
HCM
|
$ 13.95 | -3.12 % | $ 12 B | Nasdaq Global Select Market | ||
|
Aptorum Group Limited
APM
|
- | - | $ 5.72 M | Nasdaq Global Select Market | ||
|
iBio
IBIO
|
$ 0.82 | 9.38 % | $ 85.3 M | NYSE American | ||
|
Kodiak Sciences
KOD
|
$ 97.66 | 0.89 % | $ 5.2 B | Nasdaq Global Market,SPB | ||
|
Karyopharm Therapeutics
KPTI
|
$ 0.02 | -56.5 % | $ 219 | Nasdaq Global Select Market | ||
|
FSD Pharma
HUGE
|
- | 5743.5 % | $ 69.7 M | Nasdaq Capital Market | ||
|
BioAtla
BCAB
|
$ 1.74 | 0.64 % | $ 102 M | Nasdaq Global Select Market | ||
|
Catalyst Pharmaceuticals
CPRX
|
- | - | $ 3.85 B | Nasdaq Capital Market | ||
|
UroGen Pharma Ltd.
URGN
|
$ 29.77 | -0.33 % | $ 1.43 B | Nasdaq Global Select Market | ||
|
Catalyst Biosciences
CBIO
|
$ 12.46 | -4.45 % | $ 1.11 B | Nasdaq Capital Market | ||
|
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | ||
|
ADiTx Therapeutics
ADTX
|
- | - | $ 374 | Nasdaq Capital Market | ||
|
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | ||
|
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | ||
|
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | ||
|
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | ||
|
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | ||
|
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | ||
|
Apellis Pharmaceuticals
APLS
|
- | - | $ 5.18 B | Nasdaq Global Select Market,SPB | ||
|
Athira Pharma
ATHA
|
- | - | $ 269 M | Nasdaq Global Select Market | ||
|
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | ||
|
AstraZeneca PLC
AZN
|
- | - | $ 96.9 B | Nasdaq Global Select Market | ||
|
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | ||
|
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market | ||
|
EyePoint Pharmaceuticals
EYPT
|
$ 0.27 | -8.55 % | $ 19.8 K | Nasdaq Global Market | ||
|
Bio-Path Holdings
BPTH
|
- | - | $ 100 K | Nasdaq Capital Market | ||
|
Cara Therapeutics
CARA
|
- | -3.03 % | $ 260 M | Nasdaq Global Market,SPB | ||
|
ChromaDex Corporation
CDXC
|
- | -0.88 % | $ 598 M | Nasdaq Capital Market | ||
|
Caladrius Biosciences
CLBS
|
- | -16.75 % | $ 25.8 M | Nasdaq Capital Market | ||
|
Cyclacel Pharmaceuticals
CYCC
|
- | -5.98 % | $ 34.1 M | Nasdaq Capital Market | ||
|
Diffusion Pharmaceuticals
DFFN
|
- | 11.68 % | $ 8.97 M | Nasdaq Capital Market | ||
|
Eloxx Pharmaceuticals
ELOX
|
- | -5.68 % | $ 8.28 M | Nasdaq Global Market | ||
|
Enochian Biosciences
ENOB
|
- | - | $ 40.5 M | Nasdaq Capital Market | ||
|
Esperion Therapeutics
ESPR
|
- | - | $ 661 M | Nasdaq Global Market,SPB | ||
|
Evofem Biosciences
EVFM
|
- | 7.55 % | $ 38.1 M | Nasdaq Capital Market | ||
|
Eyenovia
EYEN
|
- | 49.81 % | $ 13.2 M | Nasdaq Capital Market | ||
|
FibroGen
FGEN
|
- | - | $ 889 M | Nasdaq Global Select Market,SPB | ||
|
Homology Medicines
FIXX
|
- | 0.77 % | $ 53.4 M | Nasdaq Global Select Market | ||
|
Amicus Therapeutics
FOLD
|
- | - | $ 4.47 B | Nasdaq Global Market,SPB | ||
|
Frequency Therapeutics
FREQ
|
- | - | $ 528 M | Nasdaq Global Select Market | ||
|
Galecto
GLTO
|
- | - | $ 762 M | Nasdaq Global Select Market | ||
|
GlycoMimetics
GLYC
|
- | 9357.83 % | $ 1.01 B | Nasdaq Global Market | ||
|
Graybug Vision
GRAY
|
- | -11.23 % | $ 9.65 M | Nasdaq Global Market | ||
|
Galera Therapeutics
GRTX
|
- | -32.59 % | $ 7.61 M | Nasdaq Global Market | ||
|
Happiness Biotech Group Limited
HAPP
|
- | 1.35 % | $ 17.8 M | Nasdaq Capital Market | ||
|
Novavax
NVAX
|
$ 7.91 | -0.69 % | $ 1.28 B | Nasdaq Global Select Market |